Skip to main content
. Author manuscript; available in PMC: 2011 Sep 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2010 Sep;62(9):1328–1334. doi: 10.1002/acr.20219

Table 1.

Patient Demographics and Presenting Characteristics

Patient Age at Onset (Years) Gender Race* ILD Raynaud’s Phenomenon Rash Myalgia Arthritis Dysphagia Weakness on Exam**
PU DU PL DL A
1 20 F AA -- + + + + + + + + +
2 34 F AA -- -- + -- -- + + + +
3 42 F W -- -- -- -- -- + + + +
4 72 M W -- -- -- + -- + + + + + +
5 21 F AA -- + -- + + -- + + + +
6 26 F AA -- + + -- + + + +
7 51 M W -- -- -- + + + + +
8 32 F W -- + + + -- -- + +

Key: ILD = interstitial lung disease;

*

AA= African-American, W= Caucasian

**

PU = proximal upper extremity, DU= Distal upper extremity, PL=proximal lower extremity, DL=distal lower extremity

A= asymmetrical weakness. Weakness was defined as ≤ 4 on manual muscle strength testing